HOME >> BIOLOGY >> NEWS
K-State professor examines connections between food, culture and psychology in new book

MANHATTAN, KAN. -- Do you mash your potatoes or roast them? Prefer a martini or a rum and Coke? The answers to these and other questions about what you eat can tell researchers a lot about who you are and to which social class you belong.

This is just one of the findings by Leon Rappoport, a professor of psychology at Kansas State University. In his recent book, "How We Eat: Appetite, Culture and the Psychology of Food," published in May by ECW Press, he addresses the way cultures define things as edible, food habits and ideologies, the origin of eating disorders, the relationship of food to sex and aggression, the future of marketing and the psychological implications behind these issues.

"Every aspect of eating behavior has both a social component and a psychological context," Rappoport said. "The food we eat is defined by our social class and values.

"For example, the lower classes tend to prefer sweet drinks and foods, whereas the upper class prefers dry drinks and food items that tend to be bitter, astringent, or more complex flavors that you have to develop a taste for. It has to do with the self-discipline of food," Rappoport explained.

This concept of self-control is also what links food to sex and aggression.

"Food and sex are both visceral appetites, and there's the idea that these appetites and behaviors need to be socialized and controlled," Rappoport says. "That's why we teach children manners at an early age."

As societies change, the foods that people eat and the body images they associate with status also evolve. Rappoport explains that in the 19th century, the working class typically performed physical labor, so the function of food was to fuel the body. Thus, a body we would now consider overweight was considered desirable because it was associated with prosperity, success and the sedentary lifestyle of the upper class.

"Today, however, it's the opposite," Rappoport says. "In modern society, f
'"/>

Contact: Leon Rappoport
rappo@k-state.edu
785-532-0601
Kansas State University
12-Jun-2003


Page: 1 2

Related biology news :

1. K-State, other universities to study how climate affects plant evolution
2. K-States National Agricultural Biosecurity Center receives $1.3 Million from Department of Defense
3. K-State professor combines love of teaching, research to examine eye development
4. K-State researcher working to improve alternatives to equine antibiotics
5. K-State business researchers to help with major study on food supply veterinary medicine
6. K-State researchers share $1 million grant to study insect pests
7. K-State soil carbon sequestration research playing role in climate change efforts
8. K-State uses geographic tools to track plant pathogens
9. K-State professor to give paper on potential impact of ag bioterrorism
10. K-State scientists beetle chosen for national genome sequencing project
11. New science at K-State attracts $4.2 million from National Science Foundation

Post Your Comments:
(Date:5/21/2013)... , May 21, 2013 Royal Philips Electronics ... the world,s first portable ultrasound with Philips, industry leading ... capability. The CX50 xMATRIX with available Live 3D TEE ... at the EuroPCR, official meeting for the ... Since its launch in 2012, Philips CX50 ...
(Date:5/21/2013)... modifications, which alter the way genes function without ... detected in the blood of pregnant women during ... foretell depression in the weeks after giving birth, ... debilitating. , The findings of the small study ... the journal Molecular Psychiatry . , "Postpartum ...
(Date:5/20/2013)... to the antibiotic colistin are also commonly resistant ... according to a study in mBio , ... for Microbiology. Cross-resistance to colistin and host antimicrobials ... against bacterial attack, could mean that patients with ... a crippled immune response. Colistin is a last-line ...
Breaking Biology News(10 mins):Philips CX50 xMATRIX now offers world-class interventional and diagnostic features on single portable system 2Genetic predictors of postpartum depression uncovered by Hopkins researchers 2Genetic predictors of postpartum depression uncovered by Hopkins researchers 3Resistance to last-line antibiotic makes bacteria resistant to immune system 2Resistance to last-line antibiotic makes bacteria resistant to immune system 3
(Date:5/21/2013)... Toronto, Canada (PRWEB) May 21, 2013 ... there is a strong push within the industry ... Development and Manufacturing Organizations and pharma companies often ... time frames. , Microtablets, developed in collaboration with ... how effective outsourcing can bring products to market ...
(Date:5/21/2013)... May 21, 2013 Many have long ... contributor to acne. Recently physicians from Clinical Psychiatry.com ... stress on the skin, and suggested using hypnotherapy ... the chemicals produced from stress that cause acne. , ... negative feelings acne brings about, stress causes changes in ...
(Date:5/21/2013)... Emerson Resources Inc. , a premier pharmaceutical ... Company’s Chief Executive Officer and Chairman of the Board, ... service. As part of Emerson Resources’ planned leadership succession ... as Dr. Signorino’s successor. , Dr. Signorino is ... a significant contribution to the field during his extensive ...
(Date:5/21/2013)... 21, 2013  MacroGenics, Inc. today announced that ... (MGAH22), an Fc-modified chimeric monoclonal antibody (MAb), in ... oncoprotein," will be presented at the 2013 Annual ... during the Developmental Therapeutics - Immunotherapy Oral Abstract ... 4:30 PM.  The presentation will describe the results ...
Breaking Biology Technology:The Development of an Innovative Microtablet Dosage Form, a Success Story: Live Webinar Hosted by Xtalks 2Adult Acne Treatment, Probiotic Action Explains How Hypnotherapy and Probiotics May Cure Various Skin Conditions 2Emerson Resources Announces CEO Retirement and Appointment of Successor 2Emerson Resources Announces CEO Retirement and Appointment of Successor 3MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 3
Cached News: